Monotherapy versus polytherapy of enoxaparin and hydroxychloroquine for the treatment of COVID-19: A randomized controlled clinical trial

OBJECTIVES: The current study aims to assess the efficacy and safety of Enoxaparin and hydroxychloroquine (HCQ) used as monothrapy or polytherapy versus standard care alone in Coronavirus 2019 (COVID-19) infected patients. METHODS: The current study included two hundred patients with laboratory conf...

Descripción completa

Detalles Bibliográficos
Autores principales: Said, Amira S.A., Hussein, Raghda R.S., Khalil, Doaa Mahmoud, Fahmy, Alzhraa M., Hassanein, Ahmed H.A., Abdelaty, Lamiaa N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117317/
https://www.ncbi.nlm.nih.gov/pubmed/37090452
http://dx.doi.org/10.18549/PharmPract.2023.1.2777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117317/
https://www.ncbi.nlm.nih.gov/pubmed/37090452
http://dx.doi.org/10.18549/PharmPract.2023.1.2777

Ejemplares similares